Literature DB >> 24769422

Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis.

Shurong Duan1, Zheng Lv2, Xiaoxue Fan1, Le Wang1, Fei Han1, Hong Wang1, Sheng Bi3.   

Abstract

To estimate the associations between vitamin D status and multiple sclerosis (MS). We searched electronic databases of the human literature in PubMed, EMBASE and the Cochrane Library up to February, 2014 using the following keywords: 'vitamin D' or '25(OH)D' and 'status' or 'deficiency' or 'insufficiency' and 'multiple sclerosis'. A systematic review and meta-analysis were conducted on observational studies that reported the association between blood vitamin D levels and MS. Eleven studies met the inclusion criteria. 1007 patients and 829 controls were included. Results of our meta-analysis show that MS patients had lower mean levels of 25-hydroxyvitamin D [25(OH)D] than healthy controls (weighted mean difference[MD], -14.52, 95% confidence interval [CI], -23.83 to -5.22). There were statistically significant heterogeneity (P<0.00001; I(2)=92%). The significant heterogeneity may be due to the differences in ethnicity, country, season of blood sampling and age of the participants studied. To sum up, low vitamin D levels are associated with an increased risk of MS.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  25-Hydroxy vitamin D; Deficiency; Insufficiency; Multiple sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24769422     DOI: 10.1016/j.neulet.2014.04.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.

Authors:  Cecilie Ammitzbøll; Lars Börnsen; Eva Rosa Petersen; Annette Bang Oturai; Helle Bach Søndergaard; Philippe Grandjean; Finn Sellebjerg
Journal:  J Neuroimmunol       Date:  2019-03-02       Impact factor: 3.478

2.  Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Authors:  Egil Røsjø; Linn H Steffensen; Lone Jørgensen; Jonas C Lindstrøm; Jūratė Šaltytė Benth; Annika E Michelsen; Pål Aukrust; Thor Ueland; Margitta T Kampman; Øivind Torkildsen; Trygve Holmøy
Journal:  J Neurol       Date:  2015-10-01       Impact factor: 4.849

3.  Association Between Time Spent Outdoors and Risk of Multiple Sclerosis.

Authors:  Prince Sebastian; Nicolas Cherbuin; Lisa F Barcellos; Shelly Roalstad; Charles Casper; Janace Hart; Gregory S Aaen; Lauren Krupp; Leslie Benson; Mark Gorman; Meghan Candee; Tanuja Chitnis; Manu Goyal; Benjamin Greenberg; Soe Mar; Moses Rodriguez; Jennifer Rubin; Teri Schreiner; Amy Waldman; Bianca Weinstock-Guttman; Jennifer Graves; Emmanuelle Waubant; Robyn Lucas
Journal:  Neurology       Date:  2021-12-08       Impact factor: 9.910

4.  Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population.

Authors:  Eda Sezer; Birsen Can Demirdöğen; Şeref Demirkaya; Giray Bulut; Merve Akkulak; Emre Evin; Orhan Adalı
Journal:  Neurol Sci       Date:  2021-09-21       Impact factor: 3.307

5.  Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.

Authors:  A Legitimo; V Bertini; G Costagliola; G I Baroncelli; R Morganti; A Valetto; R Consolini
Journal:  Clin Exp Immunol       Date:  2020-04-16       Impact factor: 4.330

6.  Evidence for the Importance of Vitamin D Status in Neurologic Conditions.

Authors:  Anusha K Yeshokumar; Deanna Saylor; Michael D Kornberg; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

7.  Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.

Authors:  Luisa Agnello; C Scazzone; P Ragonese; G Salemi; B Lo Sasso; R Schillaci; G Musso; C Bellia; M Ciaccio
Journal:  Neurol Sci       Date:  2015-10-27       Impact factor: 3.307

8.  Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.

Authors:  Cristina Fernandez-Carbonell; Leigh E Charvet; Lauren B Krupp
Journal:  Paediatr Drugs       Date:  2021-05-17       Impact factor: 3.022

9.  Impact of Nutritional Intake on Function in People with Mild-to-Moderate Multiple Sclerosis.

Authors:  Lacey Bromley; Peter J Horvath; Susan E Bennett; Bianca Weinstock-Guttman; Andrew D Ray
Journal:  Int J MS Care       Date:  2019 Jan-Feb

10.  Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients.

Authors:  Yesim Beckmann; Sabiha Türe; Sule Uysal Duman
Journal:  EPMA J       Date:  2019-11-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.